A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients
Year: 2015
Type: review
Source: Expert Opinion on Drug Safety
Authors: Alana Dikopf, Kevin Wood, Ravi Salgia
Institutions: University of Chicago, University of Chicago Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1981064239